Related Experiment Videos

Toxicity of 8-methoxypsoralen in cynomolgous monkeys (Macaca fascicularis)

T Rozman1, F Leuschner, R Brickl

  • 1Medizinische Forschung und Entwicklung der Basotherm GmbH, F.R.G.

Insights

This study found that vomiting is the earliest sign of 8-methoxypsoralen (8-MOP) toxicity in cynomolgous monkeys. The drug

Area of Science:

  • Pharmacology
  • Toxicology
  • Primate Studies

Background:

  • 8-methoxypsoralen (8-MOP) is a compound with therapeutic applications.
  • Understanding its chronic toxicity profile is crucial for human safety.
  • Non-human primate models are often used to predict human responses.

Purpose of the Study:

  • To evaluate the chronic oral toxicity of 8-methoxypsoralen (8-MOP) in cynomolgous monkeys.
  • To identify the most sensitive indicators of 8-MOP toxicity.
  • To assess the pharmacokinetic profile and predict human relevance.

Main Methods:

  • Male and female cynomolgous monkeys received oral 8-MOP (0, 2, 6, or 18 mg/kg) thrice weekly for 26 weeks.
  • Dose-response relationships for toxicity and pharmacokinetic parameters were analyzed.
  • Histopathological examination and clinical observations were conducted.

Main Results:

  • Dose-dependent emesis was the most sensitive indicator of 8-MOP toxicity, occurring at 3 x 6 mg/kg/week.
  • Kupffer cell proliferation was observed histologically but lacked dose-response.
  • Nonlinear pharmacokinetics with saturation between 3 x 2 and 3 x 6 mg/kg/week were noted.

Conclusions:

  • Vomiting is the earliest sign of 8-MOP toxicity in cynomolgous monkeys.
  • The pharmacokinetic profile and toxicity of 8-MOP in monkeys resemble those in humans.
  • This study suggests that chronic toxicity findings in cynomolgous monkeys are predictive for humans.

Related Concept Videos